Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada
Zishan Cui(University of British Columbia), Thomas Kerr(St. Paul's Hospital), Kanna Hayashi(Simon Fraser University), Paxton Bach(University of British Columbia), M‐J Milloy(University of British Columbia), Jeffrey Morgan(British Columbia Centre on Substance Use), Lianping Ti(University of British Columbia)
Cited by 7
Related Papers
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148
<i>Cryptococcus gattii</i>Dispersal Mechanisms, British Columbia, Canada
|Emerging infectious diseases|2007|146
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
|Drug and Alcohol Dependence|2020|119